Trials / Completed
CompletedNCT05708404
Outpatient Treatment of Severe and Enduring Anorexia Nervosa
A Novel Outpatient Treatment for Patients With Severe and Enduring Anorexia Nervosa: Patient Characteristics, Treatment Goals, and Course of Treatment.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Helsinki University Central Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Approximately 20-30 % of individuals with the eating disorder anorexia nervosa develop an enduring form of the illness. In this study a new treatment for patients with severe and enduring anorexia nervosa was described. The treatment is flexible and aims at enhancing quality of life. The participants consisted of all referrals resulting in an assessment or treatment period at the unit between May 2017 and May 2022. The study was a registry study. Information regarding patient characteristics, treatment goals, and the course of treatment was gathered from medical records.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Outpatient treatment of severe and enduring anorexia nervosa | A novel outpatient treatment of severe and enduring anorexia nervosa, aiming at enhancing quality of life and minimizing harm |
Timeline
- Start date
- 2017-05-01
- Primary completion
- 2022-05-31
- Completion
- 2022-05-31
- First posted
- 2023-02-01
- Last updated
- 2023-02-01
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT05708404. Inclusion in this directory is not an endorsement.